Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use LUMIZYME safely and effectively. See full prescribing information for LUMIZYME. LUMIZYME® (alglucosidase alfa), for injection, for intravenous use Initial U.S. Approval: 2010
Medication labelWhy this: Advisory · dailymed-prescription
LUMIZYME® is a hydrolytic lysosomal glycogen-specific enzyme indicated for patients with Pompe disease (acid α-glucosidase [GAA] deficiency).
- generic_name
- alglucosidase alfa
- product_names
- ALGLUCOSIDASE ALFA
- ndc
- 58468-0160, 58468-0160-1, 58468-0160-2
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en